Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
750.95
5.35 (0.72%)
BSENSE

Jun 18

BSE+NSE Vol: 55.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "750.95",
    "chg": 5.35,
    "chgp": "0.72%",
    "dir": 1,
    "prev_price": "745.60",
    "mcapval": "14,742.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE901L01018",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "55.79 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 13:16:02",
        "description": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 13:16:02",
        "description": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after receiving USFDA nod for Larotrectinib Capsules",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-11 14:05:12",
        "description": "Alembic Pharma gains after receiving USFDA nod for Larotrectinib Capsules  Business Standard..."
      },
      {
        "title": "Stocks to watch: Adani Energy, Hindustan Zinc, Lenskart, ZEE, Alembic Pharma, among key stocks in focus on 8 June",
        "link": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxNeVk1SkZYQkZPd0tXR21iYml1S3UzMnFLZjg1TlNTUWstSG84dUNkRFgwb0dlT1puTk1XMUpoWEhqM0l1Z2h5NDRDMkRUcVEtWmhjTnR0V21WVFlPQVpUOFNRazlRa3ZYQ29KQzUtNUJIVVhYUlJPMi05U05BVVVMV2FBSV9pdUt3MnRVS1VjWnNJSjJfZTlmbXV5YUpJaUR2NkotT2FVMVJLbndlcU1seUJxTDkySmIwODJTaTRtVXdGejJUT0NGNmVBRmxzc00wUzBFbHpyUmhEa1BNQWs3QndfbWJWb3RvR2kxRmhXUHRaYjhjMkNFR0JBb01YTTltaXhydDYxOWbSAY4CQVVfeXFMT0hKNjBaWGxtTnVnS1BoYzNzcnZfWU1WVW1Bell6cldoRXdnWGxzd3lfbmN4dkVBZXEwdHlmbUk2WXZ1d09ENEktTm5QQzRLdlRWZDdqNGxjZG1KbV96al9uSXlkZktUSG1qVWtxVTZEVXFkd0w1V2VuaE5YMjY4dm44R09ZbkpmVjFyQUNhUEExbU5fdXZRVjc5a2V2NDRTSGNrOEF1UlYzb1VSRGEzLUx3NUxWS01FblNXMzg3ank4aHcwWmJDc2RXUVo4ZllyZjhQd0R6akk2MjRaYXEtVXJ5Mmc1Z0wyRmsxWHJNNTEwTDlaZ2dJejF0el9QdlVjUlJuQ2pHdjE2WExyYmtR?oc=5",
        "imagepath": "",
        "date": "2026-06-08 07:58:51",
        "description": "Stocks to watch: Adani Energy, Hindustan Zinc, Lenskart, ZEE, Alembic Pharma, among key stocks in focus on 8 June  Mint..."
      },
      {
        "title": "Alembic Pharma receives USFDA approval for Haloperidol tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-05 11:50:52",
        "description": "Alembic Pharma receives USFDA approval for Haloperidol tablets  Business Standard..."
      },
      {
        "title": "Alembic Pharma receives USFDA approval for Haloperidol tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-05 11:50:52",
        "description": "Alembic Pharma receives USFDA approval for Haloperidol tablets  Business Standard..."
      },
      {
        "title": "Alembic Pharma gets USFDA nod for generic levothyroxine sodium tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-22 11:40:15",
        "description": "Alembic Pharma gets USFDA nod for generic levothyroxine sodium tablets  Business Standard..."
      }
    ],
    "total": 7,
    "sid": "807696",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "12-Jun-2026",
      "details": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP 0.05%.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "11-Jun-2026",
      "details": "Please find enclosed herewith the Intimation regarding re-affirmation of credit rating on Commercial Paper",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "11-Jun-2026",
      "details": "Please find enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>550%</strong> dividend, ex-date: 29 Jul 25",
          "dt": "2025-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12-Jun-2026 | Source : BSE

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP 0.05%.

Announcement under Regulation 30 (LODR)-Credit Rating

11-Jun-2026 | Source : BSE

Please find enclosed herewith the Intimation regarding re-affirmation of credit rating on Commercial Paper

Announcement under Regulation 30 (LODR)-Newspaper Publication

11-Jun-2026 | Source : BSE

Please find enclosed.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Pharmaceuticals Ltd. has declared 550% dividend, ex-date: 29 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available